GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Q2 FY27 Financial Results: PAT ₹25,333 Cr & Revenue ₹92,442 Cr

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
MetricValue
Revenue₹92,442 Cr
Net Profit (PAT)₹25,333 Cr
📢 Key Event
Management reshuffle with Natland appointed as Non-Executive Director and Akshikar reappointed as Managing Director
🔄 What Changed
Reappointment of Bhushan Akshikar as Managing Director for two years starting 1st December 2026
🔮 What's Next
None
💡 Investor Takeaway
Leadership continuity with new APAC-focused director and MD reappointment aims to drive growth in General Medicines.

GlaxoSmithKline Pharmaceuticals announced management changes effective 3rd August 2026, with Ms. Karine J F Natland appointed as Non-Executive Director and Mr. Bhushan Akshikar reappointed as Managing Director for two years starting 1st December 2026. The company also released unaudited standalone and consolidated financial results for Q1 FY2026, showing revenue of ₹98,605 lakhs and ₹98,220 lakhs respectively, with profit after tax of ₹25,333 lakhs (standalone) and ₹23,718 lakhs (consolidated).

📄 View Original Announcement (PDF)

About GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹51,721.36 Cr P/E: 49.2 ROE: 47.1% ROCE: 64.1% Div Yield: 1.87%

View full GLAXO stock details →

📡 Get AI alerts when GLAXO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLAXO — Free

📊 More GLAXO filings

See all GLAXO filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GLAXO files new disclosures

Track GLAXO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLAXO — Free

Free account · 2 AI queries/day